Safety, Biodistribution, and Dosimetry Study of Meplazumab, a Potential COVID-19 Therapeutic Drug, with I-Labeling and SPECT Imaging.

meplazumab - Jiangsu Pacific Meinuoke Biopharmaceutical, Air Force Medical University

http://www.ncbi.nlm.nih.gov/pubmed/36668905

Jan 21, 2023